(ALSN) Allison Transmission - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US01973R1014
Stock: Automatic Transmissions, Electric Propulsion, ReTran, Parts, Defense Kits
Total Rating 41
Risk 92
Buy Signal 0.43
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.15% |
| Yield on Cost 5y | 2.67% |
| Yield CAGR 5y | 9.18% |
| Payout Consistency | 98.7% |
| Payout Ratio | 17.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 27.7% |
| Relative Tail Risk | -7.45% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.07 |
| Alpha | -13.44 |
| Character TTM | |
|---|---|
| Beta | 1.006 |
| Beta Downside | 0.919 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.59% |
| CAGR/Max DD | 1.16 |
Description: ALSN Allison Transmission January 07, 2026
Allison Transmission Holdings, Inc. (NYSE: ALSN) designs, manufactures, and sells fully automatic transmissions for medium- and heavy-duty commercial vehicles, as well as electrified propulsion systems for U.S. defense platforms, serving a global customer base across distribution, construction, transit, mining, and off-highway applications.
In FY 2023 the company generated approximately $2.5 billion in revenue, with aftermarket parts and services contributing roughly 30% of total sales and delivering an operating margin near 9%; its “ReTran” remanufacturing line has grown at a 12% compound annual rate over the past three years, reflecting strong demand for cost-effective lifecycle extensions.
Key economic drivers include U.S. freight volume growth, which underpins medium- and heavy-truck orders, and rising defense spending that supports the “defense kits” segment; a material sector catalyst is the accelerating shift toward electric powertrains, where Allison’s electrified propulsion solutions are projected to expand revenue at a double-digit pace, contingent on broader EV adoption in commercial fleets.
For a deeper dive into ALSN’s valuation metrics and scenario analysis, see the ValueRay platform.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 699.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA -0.77 > 1.0 |
| NWC/Revenue: 40.18% < 20% (prev 32.12%; Δ 8.06% < -1%) |
| CFO/TA 0.15 > 3% & CFO 804.0m > Net Income 699.0m |
| Net Debt (1.50b) to EBITDA (1.07b): 1.39 < 3 |
| Current Ratio: 3.82 > 1.5 & < 3 |
| Outstanding Shares: last quarter (84.0m) vs 12m ago -4.49% < -2% |
| Gross Margin: 48.29% > 18% (prev 0.48%; Δ 4781 % > 0.5%) |
| Asset Turnover: 56.39% > 50% (prev 59.69%; Δ -3.30% > 0%) |
| Interest Coverage Ratio: 10.85 > 6 (EBITDA TTM 1.07b / Interest Expense TTM 88.0m) |
Altman Z'' 2.57
| A: 0.22 (Total Current Assets 1.67b - Total Current Liabilities 438.0m) / Total Assets 5.52b |
| B: -0.01 (Retained Earnings -70.0m / Total Assets 5.52b) |
| C: 0.18 (EBIT TTM 955.0m / Avg Total Assets 5.44b) |
| D: -0.03 (Book Value of Equity -112.0m / Total Liabilities 3.68b) |
| Altman-Z'' Score: 2.57 = A |
Beneish M -3.21
| DSRI: 0.87 (Receivables 329.0m/393.0m, Revenue 3.07b/3.20b) |
| GMI: 0.99 (GM 48.29% / 47.60%) |
| AQI: 0.98 (AQ_t 0.55 / AQ_t-1 0.56) |
| SGI: 0.96 (Revenue 3.07b / 3.20b) |
| TATA: -0.02 (NI 699.0m - CFO 804.0m) / TA 5.52b) |
| Beneish M-Score: -3.21 (Cap -4..+1) = AA |
What is the price of ALSN shares?
As of February 07, 2026, the stock is trading at USD 115.63 with a total of 863,642 shares traded.
Over the past week, the price has changed by +6.38%, over one month by +13.83%, over three months by +42.40% and over the past year by +1.33%.
Over the past week, the price has changed by +6.38%, over one month by +13.83%, over three months by +42.40% and over the past year by +1.33%.
Is ALSN a buy, sell or hold?
Allison Transmission has received a consensus analysts rating of 3.30.
Therefor, it is recommend to hold ALSN.
- StrongBuy: 2
- Buy: 1
- Hold: 5
- Sell: 2
- StrongSell: 0
What are the forecasts/targets for the ALSN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 114.8 | -0.7% |
| Analysts Target Price | 114.8 | -0.7% |
| ValueRay Target Price | 149.3 | 29.1% |
ALSN Fundamental Data Overview February 05, 2026
P/E Trailing = 13.7104
P/E Forward = 11.325
P/S = 3.0444
P/B = 4.9838
P/EG = 0.8333
Revenue TTM = 3.07b USD
EBIT TTM = 955.0m USD
EBITDA TTM = 1.07b USD
Long Term Debt = 2.39b USD (from longTermDebt, last quarter)
Short Term Debt = 5.00m USD (from shortTermDebt, last quarter)
Debt = 2.40b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.50b USD (from netDebt column, last quarter)
Enterprise Value = 10.84b USD (9.34b + Debt 2.40b - CCE 902.0m)
Interest Coverage Ratio = 10.85 (Ebit TTM 955.0m / Interest Expense TTM 88.0m)
EV/FCF = 15.82x (Enterprise Value 10.84b / FCF TTM 685.0m)
FCF Yield = 6.32% (FCF TTM 685.0m / Enterprise Value 10.84b)
FCF Margin = 22.32% (FCF TTM 685.0m / Revenue TTM 3.07b)
Net Margin = 22.78% (Net Income TTM 699.0m / Revenue TTM 3.07b)
Gross Margin = 48.29% ((Revenue TTM 3.07b - Cost of Revenue TTM 1.59b) / Revenue TTM)
Gross Margin QoQ = 47.47% (prev 49.39%)
Tobins Q-Ratio = 1.96 (Enterprise Value 10.84b / Total Assets 5.52b)
Interest Expense / Debt = 1.00% (Interest Expense 24.0m / Debt 2.40b)
Taxrate = 24.73% (45.0m / 182.0m)
NOPAT = 718.9m (EBIT 955.0m * (1 - 24.73%))
Current Ratio = 3.82 (Total Current Assets 1.67b / Total Current Liabilities 438.0m)
Debt / Equity = 1.30 (Debt 2.40b / totalStockholderEquity, last quarter 1.84b)
Debt / EBITDA = 1.39 (Net Debt 1.50b / EBITDA 1.07b)
Debt / FCF = 2.18 (Net Debt 1.50b / FCF TTM 685.0m)
Total Stockholder Equity = 1.73b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.84% (Net Income 699.0m / Total Assets 5.52b)
RoE = 40.46% (Net Income TTM 699.0m / Total Stockholder Equity 1.73b)
RoCE = 23.18% (EBIT 955.0m / Capital Employed (Equity 1.73b + L.T.Debt 2.39b))
RoIC = 17.42% (NOPAT 718.9m / Invested Capital 4.13b)
WACC = 7.81% (E(9.34b)/V(11.74b) * Re(9.62%) + D(2.40b)/V(11.74b) * Rd(1.00%) * (1-Tc(0.25)))
Discount Rate = 9.62% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.82%
[DCF Debug] Terminal Value 79.94% ; FCFF base≈694.2m ; Y1≈753.9m ; Y5≈941.6m
Fair Price DCF = 185.7 (EV 16.95b - Net Debt 1.50b = Equity 15.46b / Shares 83.2m; r=7.81% [WACC]; 5y FCF grow 9.79% → 2.90% )
EPS Correlation: -6.39 | EPS CAGR: -42.44% | SUE: -4.0 | # QB: 0
Revenue Correlation: 68.31 | Revenue CAGR: 1.97% | SUE: -2.87 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.14 | Chg30d=+0.406 | Revisions Net=+3 | Analysts=4
EPS next Year (2026-12-31): EPS=9.85 | Chg30d=+1.775 | Revisions Net=+0 | Growth EPS=+27.3% | Growth Revenue=+84.3%
P/E Forward = 11.325
P/S = 3.0444
P/B = 4.9838
P/EG = 0.8333
Revenue TTM = 3.07b USD
EBIT TTM = 955.0m USD
EBITDA TTM = 1.07b USD
Long Term Debt = 2.39b USD (from longTermDebt, last quarter)
Short Term Debt = 5.00m USD (from shortTermDebt, last quarter)
Debt = 2.40b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.50b USD (from netDebt column, last quarter)
Enterprise Value = 10.84b USD (9.34b + Debt 2.40b - CCE 902.0m)
Interest Coverage Ratio = 10.85 (Ebit TTM 955.0m / Interest Expense TTM 88.0m)
EV/FCF = 15.82x (Enterprise Value 10.84b / FCF TTM 685.0m)
FCF Yield = 6.32% (FCF TTM 685.0m / Enterprise Value 10.84b)
FCF Margin = 22.32% (FCF TTM 685.0m / Revenue TTM 3.07b)
Net Margin = 22.78% (Net Income TTM 699.0m / Revenue TTM 3.07b)
Gross Margin = 48.29% ((Revenue TTM 3.07b - Cost of Revenue TTM 1.59b) / Revenue TTM)
Gross Margin QoQ = 47.47% (prev 49.39%)
Tobins Q-Ratio = 1.96 (Enterprise Value 10.84b / Total Assets 5.52b)
Interest Expense / Debt = 1.00% (Interest Expense 24.0m / Debt 2.40b)
Taxrate = 24.73% (45.0m / 182.0m)
NOPAT = 718.9m (EBIT 955.0m * (1 - 24.73%))
Current Ratio = 3.82 (Total Current Assets 1.67b / Total Current Liabilities 438.0m)
Debt / Equity = 1.30 (Debt 2.40b / totalStockholderEquity, last quarter 1.84b)
Debt / EBITDA = 1.39 (Net Debt 1.50b / EBITDA 1.07b)
Debt / FCF = 2.18 (Net Debt 1.50b / FCF TTM 685.0m)
Total Stockholder Equity = 1.73b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.84% (Net Income 699.0m / Total Assets 5.52b)
RoE = 40.46% (Net Income TTM 699.0m / Total Stockholder Equity 1.73b)
RoCE = 23.18% (EBIT 955.0m / Capital Employed (Equity 1.73b + L.T.Debt 2.39b))
RoIC = 17.42% (NOPAT 718.9m / Invested Capital 4.13b)
WACC = 7.81% (E(9.34b)/V(11.74b) * Re(9.62%) + D(2.40b)/V(11.74b) * Rd(1.00%) * (1-Tc(0.25)))
Discount Rate = 9.62% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.82%
[DCF Debug] Terminal Value 79.94% ; FCFF base≈694.2m ; Y1≈753.9m ; Y5≈941.6m
Fair Price DCF = 185.7 (EV 16.95b - Net Debt 1.50b = Equity 15.46b / Shares 83.2m; r=7.81% [WACC]; 5y FCF grow 9.79% → 2.90% )
EPS Correlation: -6.39 | EPS CAGR: -42.44% | SUE: -4.0 | # QB: 0
Revenue Correlation: 68.31 | Revenue CAGR: 1.97% | SUE: -2.87 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.14 | Chg30d=+0.406 | Revisions Net=+3 | Analysts=4
EPS next Year (2026-12-31): EPS=9.85 | Chg30d=+1.775 | Revisions Net=+0 | Growth EPS=+27.3% | Growth Revenue=+84.3%